Safi Biotherapeutics Inc. is focused on advancing blood cell therapies through innovative manufacturing processes that address the challenges of scalability, consistency, and cost-effectiveness. The company is a partner in a Department of Defense program aimed at producing on-demand blood products, leveraging expertise in blood stem cell expansion, bioprocess optimization, and cryostorage. Their lead development programs include the production of red blood cells for trauma situations and tailored red blood cells for specific medical needs, such as those required for patients with sickle cell disease. This approach aims to alleviate blood shortages and improve transfusion outcomes.

The company's leadership team brings a wealth of experience in biologic and pharmaceutical manufacturing, regulatory submissions, and clinical development. Their collaborative efforts focus on creating alternatives to traditional blood donation methods, enhancing battlefield care, and ensuring effective blood supply in various scenarios. By integrating advanced bioprocessing techniques and a strong scientific foundation, Safi Biotherapeutics is positioned to make significant contributions to the field of cell therapy and blood product manufacturing.

United States

Safi Biotherapeutics is an early stage biotech company developing cell therapies from hematopoietic progenitor sources.

Safi Biotherapeutics Inc

Company Details